{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:37:08Z","timestamp":1790779028581,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR32490\/MED\/29\/1457"],"award-info":[{"award-number":["BT\/PR32490\/MED\/29\/1457"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.lfs.2024.123281","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T02:37:05Z","timestamp":1732675025000},"page":"123281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Semaphorins and its receptors: Emerging cellular biomarkers and therapeutic targets in autoimmune and inflammatory disorders"],"prefix":"10.1016","volume":"361","author":[{"given":"Tooba","family":"Qamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lfs.2024.123281_bb0005","first-page":"966","article-title":"Semaphorins in immune regulation and cancer: molecular mechanisms and therapeutic potential","volume":"14","author":"Shen","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.lfs.2024.123281_bb0010","first-page":"42","article-title":"Role of semaphorins in neurological autoimmune diseases: implications for therapeutic strategies","volume":"20","author":"Wang","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2024.123281_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12016-013-8360-4","article-title":"Semaphorins: their dual role in regulating immune-mediated diseases","volume":"47","author":"Vadasz","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.immuni.2012.05.026","article-title":"The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal \u03b3\u03b4 T cell function","volume":"37","author":"Witherden","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2024.123281_bb0025","first-page":"89","article-title":"Semaphorin 7A: a regulator of immune cell migration in inflammatory autoimmune diseases","volume":"255","author":"Kim","year":"2023","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2024.123281_bb0030","first-page":"341","article-title":"Targeting Semaphorin 4D to mitigate neuroinflammation in neurodegenerative diseases","volume":"27","author":"Miller","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2024.123281_bb0035","doi-asserted-by":"crossref","unstructured":"A. Kumanogoh, H. Kikutani. Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol13(11) (2013) 802\u201314, doi:https:\/\/doi.org\/10.1038\/nri3545.","DOI":"10.1038\/nri3545"},{"issue":"5","key":"10.1016\/j.lfs.2024.123281_bb0040","first-page":"1234","article-title":"Neuropilin-1 mediates immune cell migration in response to Semaphorin signaling: implications for rheumatoid arthritis","volume":"211","author":"Parker","year":"2023","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123281_bb0045","first-page":"123","article-title":"Semaphorin 3A promotes regulatory T cell development in autoimmune diseases through mTOR signaling","volume":"11","author":"Liu","year":"2023","journal-title":"Immunity & Inflammation"},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0050","first-page":"537","article-title":"Semaphorin 3A contributes to the immunosuppressive effect of mesenchymal stem cells on dendritic cells and delayed-type hypersensitivity","volume":"181","author":"Chen","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nn.3003","article-title":"Semaphorin 3E\u2013Plexin-D1 signaling controls pathway-specific synapse formation in the striatum","volume":"15","author":"Ding","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2024.123281_bb0060","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4049\/jimmunol.1601514","article-title":"Semaphorin 3E deficiency exacerbates airway inflammation, hyperresponsiveness, and remodeling in a mouse model of allergic asthma","volume":"198","author":"Movassagh","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0065","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/cvr\/cvx190","article-title":"Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation","volume":"113","author":"Wu","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123281_bb0070","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.febslet.2013.05.023","article-title":"B-regulatory cells in autoimmunity and immune mediated inflammation","volume":"587","author":"Vadasz","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2024.123281_bb0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature12428","article-title":"Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis","volume":"501","author":"Delgoffe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123281_bb0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12038-015-9566-9","article-title":"Semaphorin 4A enhances lung fibrosis through activation of Akt via PlexinD1 receptor","volume":"40","author":"Peng","year":"2015","journal-title":"J. Biosci."},{"issue":"11","key":"10.1016\/j.lfs.2024.123281_bb0085","first-page":"707","article-title":"The role of semaphorins in the immune system","volume":"22","author":"Kumanogoh","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0090","first-page":"38","article-title":"Semaphorin 4A as a regulator of Th1 cell polarization and its potential implications for autoimmune diseases","volume":"68","author":"Matsuoka","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2024.123281_bb0095","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.4049\/jimmunol.1003485","article-title":"Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses","volume":"186","author":"Nakagawa","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0100","first-page":"50","article-title":"Semaphorin 4B influences T cell differentiation and cytokine production","volume":"7","author":"Jin","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0105","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1097545","article-title":"The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras","volume":"305","author":"IsaoOinuma","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.123281_bb0110","first-page":"3917","article-title":"Semaphorin 4D regulates B cell development and function: insights into its role in immune responses","volume":"191","author":"Chaudhury","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0115","first-page":"370","article-title":"The impact of Semaphorin 4D on B cell activation and antibody production","volume":"5","author":"Yoshida","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0120","first-page":"2005","article-title":"Semaphorin 4D modulates B cell migration and follicle formation","volume":"231","author":"Lee","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2024.123281_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bcp.2015.11.019","article-title":"Identification of new highly selective inhibitors of the human ADP\/ATP carriers by molecular docking and in vitro transport assays","volume":"100","author":"Todisco","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123281_bb0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/19336918.2016.1197479","article-title":"Transmembranesemaphorins: multimodal signaling cues in development and cancer","volume":"10","author":"Gurrapu","year":"2016","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.lfs.2024.123281_bb0135","first-page":"227","article-title":"The role of Semaphorin 6A in synaptic plasticity and neurological disorders","volume":"12","author":"Yuan","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.lfs.2024.123281_bb0140","first-page":"800","article-title":"Semaphorin 6A signaling in neural development","volume":"99","author":"Tran","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.123281_bb0145","first-page":"890","article-title":"Semaphorin 6B promotes tumor progression by modulating the tumor microenvironment","volume":"45","author":"Tanaka","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.123281_bb0150","first-page":"5046","article-title":"Semaphorin 6B directs axon guidance by interacting with Plexin A and neuropilin receptors","volume":"20","author":"Mayer","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2024.123281_bb0155","first-page":"85","article-title":"The role of Semaphorin 6B in the development of neural circuits: implications for axon guidance","volume":"262","author":"He","year":"2003","journal-title":"Dev. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2024.123281_bb0160","first-page":"686","article-title":"Semaphorin 6C regulates the migration of dendritic cells and T cells","volume":"99","author":"Lee","year":"2022","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123281_bb0165","doi-asserted-by":"crossref","unstructured":"Yamashita, N., Ohnuma, M., & Kudo, T. The role of Semaphorin 6C in muscle cell differentiation and regeneration. Journal of Cell Science, 135(4)(2022) jcs258964, doi:https:\/\/doi.org\/10.1242\/jcs.258964.","DOI":"10.1242\/jcs.258964"},{"issue":"1","key":"10.1016\/j.lfs.2024.123281_bb0170","first-page":"65","article-title":"The protective role of Semaphorin 6D in cardiovascular diseases","volume":"118","author":"Zhang","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123281_bb0175","first-page":"1113","article-title":"Semaphorin 6D modulates T cell activation and differentiation: insights into its role in immune responses","volume":"196","author":"Li","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0180","first-page":"47","article-title":"Semaphorin 6E regulates immune responses by modulating T-cell function","volume":"232","author":"Liu","year":"2022","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0185","first-page":"317","article-title":"Semaphorin 7A promotes T-cell responses and inflammation through its interaction with integrins","volume":"22","author":"Suzuki","year":"2021","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2024.123281_bb0190","first-page":"1967","article-title":"The role of Semaphorin 7A in neuronal growth cone collapse and synaptic plasticity","volume":"42","author":"Morales","year":"2022","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2024.123281_bb0195","first-page":"1245","article-title":"The role of Semaphorin 3C in modulating joint inflammation and destruction in rheumatoid arthritis","volume":"40","author":"Smith","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"12","key":"10.1016\/j.lfs.2024.123281_bb0200","article-title":"Semaphorin 3A as a potential therapeutic target in rheumatoid arthritis","volume":"131","author":"Catalano","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.lfs.2024.123281_bb0205","first-page":"1587","article-title":"Semaphorin 5A regulates the migration of immune cells in rheumatoid arthritis","volume":"56","author":"Zhu","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lfs.2024.123281_bb0210","first-page":"3714","article-title":"Semaphorin 3A regulates the migration and activation of rheumatoid arthritis synovial fibroblasts","volume":"64","author":"Miyazaki","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2024.123281_bb0215","article-title":"The role of Semaphorin 3A in the pathogenesis of rheumatoid arthritis: potential for novel therapeutic strategies","volume":"2015","author":"Kang","year":"2015","journal-title":"J Immunol Res"},{"issue":"11","key":"10.1016\/j.lfs.2024.123281_bb0220","first-page":"1908","article-title":"Semaphorin 4D-Plexin-B1 signaling attenuates autoimmune inflammation through the control of Tfh cell responses in lupus-prone mice","volume":"71","author":"Kumanogoh","year":"2019","journal-title":"Arthritis & Rheumatology (Hoboken, N.J.)"},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0225","first-page":"341","article-title":"Semaphorin 4D-Plexin-B1 signaling controls autoimmune inflammation by regulating the migration and functions of T follicular helper cells in lupus mice","volume":"78","author":"Kumanogoh","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.lfs.2024.123281_bb0230","first-page":"779","article-title":"Inactivation of TGF\u03b2 signaling in fibroblasts in systemic sclerosis attenuates fibrosis and induces expression of caveolin-1","volume":"71","author":"Distler","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2024.123281_bb0235","first-page":"5605","article-title":"Semaphorin 7A contributes to the pathogenesis of systemic sclerosis by promoting fibroblast activation and collagen production","volume":"193","author":"Guo","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0240","first-page":"55","article-title":"Role of Semaphorin 7A in the development of systemic sclerosis: implications for treatment","volume":"18","author":"Zhao","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0245","first-page":"1039","article-title":"Semaphorin 3A inhibits human dermal fibroblast proliferation and migration: a potential therapeutic for systemic sclerosis?","volume":"64","author":"Del Galdo","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2024.123281_bb0250","doi-asserted-by":"crossref","unstructured":"Falk, Ronald J., and Jennette, J. Charles. Semaphorins and their receptors in ANCA-associated vasculitis: pathogenic and therapeutic implications. Arthritis Res. Ther. 12(5) (2010 )206, doi:https:\/\/doi.org\/10.1186\/ar3098.","DOI":"10.1186\/ar3098"},{"issue":"9","key":"10.1016\/j.lfs.2024.123281_bb0255","first-page":"1838","article-title":"Altered semaphorin 3A expression in ANCA-associated vasculitis: potential role in disease pathogenesis","volume":"19","author":"Rico","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2024.123281_bb0260","first-page":"1458","article-title":"Semaphorin 3A regulates airway smooth muscle hyperreactivity and remodelling via PGD2","volume":"9","author":"Roche","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123281_bb0265","first-page":"632","article-title":"Increased expression of semaphorin 4D in bronchial tissues of asthmatic patients","volume":"63","author":"Suzuki","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.lfs.2024.123281_bb0270","first-page":"201","article-title":"Semaphorin 7A promotes airway inflammation and airway hyperresponsiveness in mice","volume":"131","author":"Mizuguchi","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2024.123281_bb0275","first-page":"2107","article-title":"Semaphorin 3A regulates epithelial-mesenchymal transition and metastasis in lung cancer cells","volume":"26","author":"Winterbottom","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2024.123281_bb0280","first-page":"1272","article-title":"Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice","volume":"119","author":"Maione","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2024.123281_bb0285","first-page":"673","article-title":"A role for SEMA6A in the regulation of transforming growth factor-\u03b21-mediated lung cancer cell invasion","volume":"42","author":"Roos","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0290","first-page":"283","article-title":"Sema4D\/CD100-plexin-B1 interactions promote human aortic smooth muscle cell migration","volume":"477","author":"Zhu","year":"2016","journal-title":"BiochemBiophys Res Commun."},{"key":"10.1016\/j.lfs.2024.123281_bb0295","first-page":"3037","article-title":"Semaphorin 4D cooperates with integrin \u03b16\u03b21 to promote macrophage migration and may be a therapeutic target in atherosclerosis","volume":"126","author":"Zhou","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.123281_bb0300","first-page":"1575","article-title":"Semaphorin 4D expression is associated with carotid atherosclerotic plaque instability","volume":"58","author":"Wanschel","year":"2013","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.lfs.2024.123281_bb0305","first-page":"2515","article-title":"Semaphorin 4D enhances pro-inflammatory responses and accelerates the development of atherosclerosis","volume":"1852","author":"Lyu","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.lfs.2024.123281_bb0310","first-page":"6375","article-title":"Semaphorin 4D promotes macrophage recruitment and clearance of apoptotic cells","volume":"182","author":"Uchida","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123281_bb0315","first-page":"781","article-title":"Targeting SEMA5A alleviates rheumatoid arthritis via inhibiting immune responses and osteoclastogenesis","volume":"79","author":"Yang","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"#cr-split#-10.1016\/j.lfs.2024.123281_bb0320.1","unstructured":"Zhang, X., Zhang, Y., Li, M., Zhou, S., & Zhang, X. (2018). Monoclonal antibody against SEMA5A attenuates inflammatory responses and joint damage in collagen-induced arthritis rats. Clinical and Experimental Rheumatology 36"},{"key":"#cr-split#-10.1016\/j.lfs.2024.123281_bb0320.2","unstructured":"(5) (2018) 875-883, doi:https:\/\/doi.org\/10.1136\/clinexpimmunol-2018-212477."},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0325","first-page":"555","article-title":"VX15\/2503: a monoclonal antibody against Sema4D for the treatment of cancer and autoimmune diseases","volume":"72","author":"Dahlhaus","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2024.123281_bb0330","unstructured":"Zhang, H., Zhang, F., & Chen, Q. (2023). Therapeutic potential of SEMA4D blockade in rheumatoid arthritis: insights from VX15\/2503. Clinical and Experimental Immunology, 212(2),(2023) 265\u2013276,doi:https:\/\/doi.org\/10.1111\/cei.13872."},{"issue":"1","key":"10.1016\/j.lfs.2024.123281_bb0335","first-page":"215","article-title":"The role of SEMA4D in the pathogenesis of systemic lupus erythematosus","volume":"38","author":"Wang","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123281_bb0340","first-page":"1","article-title":"Targeting SEMA4D in systemic lupus erythematosus: a potential therapeutic approach with a monoclonal antibody","volume":"22","author":"Luo","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2024.123281_bb0345","first-page":"4057","article-title":"SEMA4D and multiple sclerosis: a novel therapeutic target","volume":"13","author":"Bucolo","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2024.123281_bb0350","first-page":"1473","article-title":"Inhibition of semaphorin 3A activity rescues axonal growth cone collapse in neurodegenerative disorders, suggesting that blocking SEMA3A can modulate immune pathways relevant to SLE","volume":"104","author":"Suzuki","year":"2008","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.lfs.2024.123281_bb0355","first-page":"957","article-title":"SEMA4D as a therapeutic target for central nervous system diseases: progress and challenges","volume":"24","author":"Jones","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2024.123281_bb0360","first-page":"70","article-title":"Anti-SEMA4D monoclonal antibody VX15\/2503 attenuates multiple sclerosis disease progression by modulating immune cell activity and infiltration","volume":"13","author":"Ji","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0365","first-page":"311","article-title":"SM-345431, a selective Sema4D inhibitor, shows promise in clinical trials for autoimmune diseases","volume":"20","author":"Kawano","year":"2023","journal-title":"Clin. Trials"},{"issue":"1","key":"10.1016\/j.lfs.2024.123281_bb0370","article-title":"Evaluation of SM-345431 in patients with systemic lupus erythematosus: results from a Phase I trial","volume":"10","author":"Takahashi","year":"2023","journal-title":"Lupus Science & Medicine"},{"issue":"17","key":"10.1016\/j.lfs.2024.123281_bb0375","first-page":"6341","article-title":"Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.123281_bb0380","first-page":"1363","article-title":"Xanthofulvin, a novel semaphorin inhibitor, promotes regeneration of injured axons in rat spinal cord","volume":"8","author":"Tanaka","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.123281_bb0385","first-page":"1354","article-title":"Small-molecule inhibition of semaphorin 3A signaling promotes recovery after stroke","volume":"149","author":"Nakamura","year":"2012","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.lfs.2024.123281_bb0390","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s00018-012-1019-0","article-title":"Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions","volume":"69","author":"Hota","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2024.123281_bb0395","first-page":"6787","article-title":"A novel function for a conserved protein family: TASI-1 inhibits semaphorin 4D-mediated immune responses","volume":"181","author":"Barrow","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0400","doi-asserted-by":"crossref","unstructured":"Zhang, L., Wu, Y., & Wang, Z . CRISPR\/Cas9-mediated knockout of SEMA3E ameliorates neuroinflammation and enhances nerve regeneration in a mouse model of multiple sclerosis. Mol. Ther., 31(2023) 987\u2013998, doi:https:\/\/doi.org\/10.1016\/j.ymthe.2023.01.012.","DOI":"10.1016\/j.ymthe.2023.01.012"},{"issue":"8","key":"10.1016\/j.lfs.2024.123281_bb0405","first-page":"3376","article-title":"CRISPR\/Cas9-mediated SEMA3E knockout suppresses migration and invasion of human glioma cells","volume":"57","author":"Shin","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2024.123281_bb0410","article-title":"Targeted deactivation of Semaphorin 3E using CRISPR\/Cas9 technology reduces disease severity in a mouse model of multiple sclerosis","volume":"373","author":"Zhang","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.lfs.2024.123281_bb0415","first-page":"2389","article-title":"Therapeutic targeting of Sema4A in autoimmune uveitis using RNA interference","volume":"30","author":"Huang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2024.123281_bb0420","first-page":"50","article-title":"AAV-based gene therapy for ocular diseases: current status and future directions","volume":"24","author":"Zhang","year":"2023","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"10.1016\/j.lfs.2024.123281_bb0425","unstructured":"C. G. Wang, L. Zhang, et al. The therapeutic potential of iRGD in autoimmune diseases: a comprehensive review.Frontiers in Pharmacology, 15, (2024)892358,doi:https:\/\/doi.org\/10.3389\/fphar.2024.892358."},{"key":"10.1016\/j.lfs.2024.123281_bb0430","first-page":"228","article-title":"Targeting neuropilin-1 with iRGD enhances drug delivery in autoimmune conditions","volume":"354","author":"Talekar","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2024.123281_bb0435","first-page":"530","article-title":"TWLPPR: a novel NRP1-targeting peptide for modulating immune responses in autoimmune diseases","volume":"28","author":"Leung","year":"2023","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"key":"10.1016\/j.lfs.2024.123281_bb0440","article-title":"Evaluation of TWLPPR as a targeted therapy for autoimmune diseases","volume":"232","author":"Siu","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0445","first-page":"683","article-title":"CRISPR\/Cas9-mediated knockout of Semaphorin 3E in a mouse model of multiple sclerosis: therapeutic potential and mechanistic insights","volume":"29","author":"Zhang","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.lfs.2024.123281_bb0450","article-title":"Utilizing CRISPR\/Cas9 to target Semaphorin 3E in experimental autoimmune encephalomyelitis: implications for multiple sclerosis therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123281_bb0455","first-page":"449","article-title":"SEMA3E knockout attenuates retinal ganglion cell apoptosis by relieving neuroinflammation in a rat model of chronic glaucoma","volume":"68","author":"Tong","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2024.123281_bb0460","first-page":"655","article-title":"RNA interference targeting Semaphorin 4A alleviates experimental arthritis in mice","volume":"193","author":"Li","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0465","first-page":"202","article-title":"Peptide-based inhibition of SEMA3A-NRP1 signaling alleviates systemic lupus erythematosus","volume":"20","author":"Chen","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2024.123281_bb0470","doi-asserted-by":"crossref","unstructured":"G. S. O. Prasad, J. M. L. Soares, et al. Neuropilin-1 as a key player in the pathogenesis of autoimmune diseases.Frontiers in Immunology, 14, (2022)1028901,doi:https:\/\/doi.org\/10.3389\/fimmu.2023.1028901.","DOI":"10.3389\/fimmu.2023.1080310"},{"key":"10.1016\/j.lfs.2024.123281_bb0475","first-page":"3705","article-title":"Immune semaphorins: a new area of semaphorin research","volume":"126","author":"Kumanogoh","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2024.123281_bb0480","first-page":"254","article-title":"Semaphorin 3A: a new player in immune regulation","volume":"9","author":"Yang","year":"2008","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123281_bb0485","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tibs.2008.01.006","article-title":"Semaphorin signaling: progress made and promises ahead","volume":"33","author":"Zhou","year":"2008","journal-title":"Trends Biochem. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:42:01Z","timestamp":1736167321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524008713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":98,"alternative-id":["S0024320524008713"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123281","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaphorins and its receptors: Emerging cellular biomarkers and therapeutic targets in autoimmune and inflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123281"}}